Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Life Sciences
|
May 14, 2021
SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer
Surya Kant Tripathi, Bijesh Kumar Biswal
Drug Discovery Today
|
February 13, 2021
Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma
Surya Kant Tripathi, Bijesh K Biswal
Molecular Biology Reports
|
September 30, 2018
Pterospermum acerifolium (L.) wild bark extract induces anticarcinogenic effect in human cancer cells through mitochondrial-mediated ROS generation
Surya Kant Tripathi, Bijesh K Biswal
Pharmacological Research
|
April 14, 2020
Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
Surya Kant Tripathi, Bijesh Kumar Biswal
Physical Chemistry Chemical Physics : PCCP
|
November 22, 2022
Janus zirconium halide ZrXY (X, Y = Br, Cl and F) monolayers with high lattice thermal conductivity and strong visible-light absorption
Janpreet Singh, Gurinder Singh, Surya Kant Tripathi
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
January 28, 2019
Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy
Surya Kant Tripathi, Munmun Panda, Bijesh K Biswal
Biochimica Et Biophysica Acta. Reviews on Cancer
|
February 1, 2021
SOX9: An emerging driving factor from cancer progression to drug resistance
Munmun Panda, Surya Kant Tripathi, Bijesh K Biswal
Molecular Biology Reports
|
May 24, 2020
Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation
Munmun Panda, Surya Kant Tripathi, Bijesh K Biswal
Drug Discovery Today
|
May 31, 2022
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance
Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar Biswal
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 27, 2024
Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells
Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar Biswal
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Life Sciences
|
May 14, 2021
SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer
Surya Kant Tripathi, Bijesh Kumar Biswal
Drug Discovery Today
|
February 13, 2021
Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma
Surya Kant Tripathi, Bijesh K Biswal
Molecular Biology Reports
|
September 30, 2018
Pterospermum acerifolium (L.) wild bark extract induces anticarcinogenic effect in human cancer cells through mitochondrial-mediated ROS generation
Surya Kant Tripathi, Bijesh K Biswal
Pharmacological Research
|
April 14, 2020
Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
Surya Kant Tripathi, Bijesh Kumar Biswal
Physical Chemistry Chemical Physics : PCCP
|
November 22, 2022
Janus zirconium halide ZrXY (X, Y = Br, Cl and F) monolayers with high lattice thermal conductivity and strong visible-light absorption
Janpreet Singh, Gurinder Singh, Surya Kant Tripathi
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association
|
January 28, 2019
Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy
Surya Kant Tripathi, Munmun Panda, Bijesh K Biswal
Biochimica Et Biophysica Acta. Reviews on Cancer
|
February 1, 2021
SOX9: An emerging driving factor from cancer progression to drug resistance
Munmun Panda, Surya Kant Tripathi, Bijesh K Biswal
Molecular Biology Reports
|
May 24, 2020
Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation
Munmun Panda, Surya Kant Tripathi, Bijesh K Biswal
Drug Discovery Today
|
May 31, 2022
SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance
Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar Biswal
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
January 27, 2024
Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells
Surya Kant Tripathi, Rajeev Kumar Sahoo, Bijesh Kumar Biswal
Page
of 4